ExpreS2ion publishes filmed scientific interview on the cVLP COVID-19 vaccine development
ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed scientific talk on the development of the cVLP COVID-19 vaccine has been published on the company’s website. The video features Dr. Max M Søgaard from ExpreS2ion and Dr. Ali Salanti from ExpreS2ion’s joint venture and development partner AdaptVac.In the interview, Drs. Max M Søgaard and Ali Salanti talk about the rapid development process of the cVLP COVID-19 vaccine, and how it was made possible through a great collaborative effort between several industry entities and financiers.